Find Expert Doctors on Homozygous Familial Hypercholesterolemia147 top medical experts on Homozygous Familial Hypercholesterolemia across 23 countries and 5 U.S. states, including 16 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.
- Homozygous Familial Hypercholesterolemia: A rare inherited genetic disorder, one form of hyperlipoproteinemia type II, characterized by high level of LOW-density lipoprotein (LDL) which if not treated could elevate the chance of heart attack at an early age.
- Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
- Broader Categories (#Experts): Hyperlipoproteinemia Type II (2,231).
- Synonyms: Autosomal Recessive Hypercholesterolemia, HoFH
- Rosenson, Robert S Cardiovascular Disease
Zena and Michael A. Wiener Cardiovascular Institute, Marie-Josee and Henry R. Kravis Center for Cardiovascular Health. Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: . Top HospitalPhysicianMedical school: Tulane University School of Medicine (MD, 1983)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 72.4/100Disclosed payments in 2021 from 20 biomedical companies, totalling $14,659.26, including $11,654.61 from Regeneron Pharmaceuticals, Inc. - Tromp, Tycho R Department of Vascular Medicine, Amsterdam University Medical Centers, Location Academic Medical Center, Amsterdam, The Netherlands.ScientistCategories: Complications; Drug Therapy
- Kuehn, Bridget M ScientistSubjects: Antibodies, Monoclonal; Drug Approval; Fees, PharmaceuticalCategories: Economics; Administration & Dosage; Drug Therapy
- Raal, Frederick J Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of Witwatersrand, Johannesburg, South Africa.Scientist Clinical TrialSubjects: Antibodies, Monoclonal, Humanized; Outcome Assessment, Health CareCategories: Drug Therapy; Complications; Statistics & Numerical Data; Therapeutic Use
- Ray, Kausik K Imperial Centre for Cardiovascular Disease Prevention, Department of Primary Care and Public Health, School of Public Health, Imperial College London, London, UK.Scientist Clinical TrialSubjects: AtherosclerosisCategories: Complications; Drug Therapy
- Patel, Dharmesh S Cardiovascular Disease Stern Cardiovascular Foundation, Memphis, USA.PhysicianMedical school: Other (MD, 1996)Medicare Accepted; Medicare MIPS (Merit-based Incentive Payment System) rating: 88/100Disclosed payments in 2021 from 247 biomedical companies, totalling $180,866.49, including $100,084.64 from Janssen Pharmaceuticals, IncSubjects: Atherosclerosis
- Merkesdal, Sonja Medical School of Hanover, Hanover, Germany; r-connect ltd.Scientist ReviewSubjects: Cost-Benefit Analysis; Hemophilia A; Hemophilia B; Orphan Drug Production; Technology Assessment, BiomedicalCategories: Drug Therapy
- Wagle, Julia Annabel Roche Pharma AG.Scientist ReviewSubjects: Cost-Benefit Analysis; Hemophilia A; Hemophilia B; Orphan Drug Production; Technology Assessment, BiomedicalCategories: Drug Therapy
- Bansal, Sandeep Penn Highlands Healthcare, Department of Cardiology, Vardhman Mahavir Medical College and Safdarjung Hospital, Room no. 754, Super Specialty Block, New Delhi 110029, India Dr Bansal. Electronic address: .Physician Clinical TrialSubjects: Antibodies, Monoclonal, Humanized; Outcome Assessment, Health CareCategories: Drug Therapy; Statistics & Numerical Data; Therapeutic Use
- Alothman, Latifah Research Institute of the McGill University Health Centre, Montreal QC H4A 3J1, Canada.Scientist ReviewSubjects: Quality of Life
- Genest, Jacques Research Institute of the McGill University Health Centre, Montreal QC H4A 3J1, Canada.Physician ReviewSubjects: Atherosclerosis; Quality of Life
- Akioyamen, Leo E Department of Medicine, University of Toronto, Toronto ON, M5S 1A8, Canada. Electronic address: .Scientist ReviewSubjects: Atherosclerosis; Quality of Life
- Brunham, Liam R Department of Medicine, University of British Columbia, Vancouver, V5Z 1M9, Canada; Centre for Heart Lung Innovation, University of British Columbia, Vancouver, V6Z 1Y6, Canada.Scientist ReviewSubjects: Atherosclerosis; Quality of Life
- Gaudet, Daniel Department of Medicine, Clinical Lipidology & Rare Lipid Disorders Unit, Community Genomic Medicine Center, Université de Montréal & ECOGENE-21 Clinical & Translational Research Center, Chicoutimi, Québec, Canada.PhysicianSubjects: Atherosclerosis
- Bertolini, Stefano Department of Internal Medicine, University of Genova, Genova, Italy.ScientistCategories: Complications; Drug Therapy
- Freiberger, Tomas Centre for Cardiovascular Surgery and Transplantation, Brno, Czech Republic; Medical Faculty, Masaryk University, Brno, Czech Republic.ScientistCategories: Complications; Drug Therapy
- Harada-Shiba, Mariko Department of Molecular Pathogenesis, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan.ScientistCategories: Complications; Drug Therapy
These expert listings are
for individual use without a fee. Biotechs,
Pharmaceuticals, Recruiters, Consultants, Investors, Law firms, and
other organizations may use this only for quick evaluations (no downloads, screen scraping or using the data) to identify the top medical experts for recruiting, advisory panels, boards,
and consulting. Please contact
us for licensing, customized queries, feedback and questions.
Note:
- These experts have limited publications on this topic in our database, so expertise assessment may not be accurate.
- Only the top 20 experts are shown. You may filter your results or use the geolocation tabs. Contact us to purchase the entire list.